• Tetracycline Hydrochloride Assay Workflows

  2026-08-19

  Build reproducible bacterial growth, Staphylococcus aureus susceptibility, and skin microbiome workflows with a mechanism-matched tetracycline control. This guide also shows how to distinguish ribosomal translation inhibition from the rapid ROS-driven cancer-cell death reported for carrier-platin.

• Calcitriol Workflows for VDR and Decidualization

  2026-08-19

  Use Calcitriol, the active 1,25-dihydroxy vitamin D3 metabolite, to connect vitamin D receptor signaling with endometrial decidualization, immune modulation research, and cancer pathway assays. This practical guide emphasizes solvent handling, time-course design, orthogonal readouts, and troubleshooting for reproducible results.

• EdU Imaging Kits (HF594): S-Phase in Context

  2026-08-18

  EdU Imaging Kits (HF594) enable precise S-phase DNA synthesis measurement without harsh DNA denaturation. This guide shows how to interpret proliferation alongside Treg differentiation and metabolic mechanisms highlighted in recent asthma research.

• Carfilzomib (PR-171) in Proteasome Research

  2026-08-18

  Carfilzomib (PR-171) enables precise, irreversible proteasome inhibition for studying proteotoxic stress, apoptosis, and combination responses. This workflow translates recent ESCC radiosensitization findings into practical cell-based assays while emphasizing solvent control, orthogonal readouts, and reproducible dosing.

• MPTP Opening as a Translational Cell-Death Signal

  2026-08-17

  A mechanistic and strategic guide to using MPTP opening as a functional bridge between mitochondrial dysfunction, intrinsic apoptosis, and translational cell-death research.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-08-17

  The 2025 reference study shows that naturally occurring angiotensin peptides can modify SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1 in antibody-based assays. Its peptide-truncation and residue-modification strategy identifies angiotensin IV and related shorter peptides as stronger enhancers than the longer Angiotensin I decapeptide, while also defining important limits for interpreting these findings in infection or cardiovascular models.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-08-16

  Liu and colleagues show that social interaction initiates α- and γ-secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, generating an intracellular NLG1-CTD fragment that supports synaptic remodeling and social memory maintenance. The study combines behavioral, genetic, pharmacological, biochemical, and peptide-rescue approaches to connect extracellular social cues with cofilin-regulated spine plasticity.

• From Calpain Biology to Translational Cancer Strategy

  2026-08-15

  Calpain Inhibitor II, ALLM offers a practical way to interrogate protease-dependent apoptosis and protein turnover. This thought-leadership article connects calpain-2–FAK regulation in triple-negative breast cancer with assay strategy in leukemia and lymphoma, while defining what ALLM can—and cannot—prove in translational research.

• YC-1 Workflows for Hypoxia Cancer Research

  2026-08-14

  Build more informative hypoxia experiments with YC-1 by pairing HIF-1α pathway measurements with viability, angiogenesis, and soluble guanylyl cyclase readouts. This guide adapts a rigorously staged fluorometric assay framework to improve formulation control, interference testing, dose–response analysis, and mechanism-aware interpretation.

• H 89 2HCl: Reliable PKA Pathway Assays

  2026-08-14

  Learn how H 89 2HCl (SKU B2190) can clarify cAMP/PKA signaling in viability, proliferation, phosphorylation, and osteoclastogenesis workflows. This scenario-based guide covers solvent compatibility, concentration selection, assay controls, off-target interpretation, and practical supplier evaluation.

• NVP-BGJ398 Phosphate: Reading FGFR3 Evidence

  2026-08-13

  NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for dissecting pathway-dependent phenotypes in cancer and skeletal disease models. This article focuses on how to interpret genetic, pharmacological, signaling, and tissue-level evidence without confusing pathway inhibition with disease-specific efficacy.

• MTT Assay Workflows for Cell Viability Research

  2026-08-13

  Build more reliable colorimetric cell viability assays with MTT by controlling cell density, formazan solubilization, plate effects, and metabolic confounders. A lung cancer and mesenchymal stem cell study shows how MTT can anchor a broader workflow that connects viability results with proliferation, migration, invasion, and pathway analyses.

• CARMIL Membrane Binding Controls Actin Assembly

  2026-08-12

  The reference study identifies the CARMIL membrane-binding domain as an active regulator of capping protein rather than a passive membrane tether. Its results support a dynamic model in which CARMIL recruits capping protein and actin assembly machinery to membranes, then disengages after capping protein binding to promote uncapping and soluble capping-protein activity.

• Amyloid Beta-Peptide (1-40): Research Workflows

  2026-08-12

  Build reproducible aggregation, membrane-interaction, and neurotoxicity assays with a defined human Aβ40 sequence. This guide translates calcium-sensitive surface measurements into practical workflows for Alzheimer’s disease research peptide applications, including controls, optimization, and troubleshooting.

• Pseudo-UTP for Modified mRNA Synthesis

  2026-08-11

  Pseudo-UTP is a pseudouridine-containing UTP substitute for in vitro transcription and mRNA synthesis with pseudouridine modification. Its use can support RNA stability enhancement, translation, and reduced innate immune activation, but outcomes depend on transcript design, polymerase conditions, purification, and cell context.

8113 records 4/541 page Previous Next 12345 下5页 Last page